---
$id: https://graph.org.ai/products/commodity/51361933
$type: Product
source: UNSPSC
code: "51361933"
title: "Butalbital sodium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butalbital sodium

**UNSPSC Code**: 51361933
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C11H15N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BBH31P2ABJ, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-(1-methylethyl)-5-(2-propenyl)-, monosodium salt but more generally known as butalbital sodium, which bears US NIH Compound Identifier 6464. European Medicines Agency schedules Butalbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00910MIG. Most nations, for tariff and trade purposes, schedule butalbital sodium under HS 29335390 and SITC 51576. As of Q4 2014, BUTALBITAL SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC(C)CC1(C(=O)NC(=O)[N-]C1=O)CC=C.[NA+].

